Who is sponsoring NCT06134843?

NCT06134843 is sponsored by Hobart W. Harris.

What condition does NCT06134843 study?

NCT06134843 studies Skin Graft Complications.

What is the status of NCT06134843?

NCT06134843 is currently NOT_YET_RECRUITING.

Last reviewed 2024-06-11 · How we verify

Study to Assess the Safety and Efficacy of DERMASEAL for the Treatment of Split-Thickness Skin Graft Donor Site Wounds

NCT06134843 PHASE1, PHASE2 NOT_YET_RECRUITING

The goal of this study to determine whether the combination biologic/drug DERMASEAL will safely decrease donor wound pain after split-thickness skin graft surgery. Participants will have their skin graft donor sites immediately treated with DERMASEAL versus standard of care wound dressings followed by periodic monitoring of their recovery.

Details

Lead sponsor	Hobart W. Harris
Phase	PHASE1, PHASE2
Status	NOT_YET_RECRUITING
Enrolment	12
Start date	Sun Sep 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue Apr 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Skin Graft Complications

Interventions

DERMASEAL